Drugs / cmv vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT01195571 Comparator | Sep 2010 → Oct 2014 | cytomegalovirus infection | CMV Research Foundation | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | cmv vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01195571 ↗ |
| Modality | Vaccine | “four new investigational Cytomegalovirus (CMV) vaccines” NCT01195571 ↗ |
| Route | Subcutaneous | “will be administered subcutaneously” NCT01195571 ↗ |